Phase Ib/II study of weekly topotecan and daily gefitinib in patients with platinum resistant ovarian, peritoneal, or fallopian tube cancer
Chelariu-Raicu, Anca, Levenback, Charles F, Slomovitz, Brian M, Wolf, Judith, Bodurka, Diane C, Kavanagh, John J, Morrison, Christopher, Gershenson, David M, Coleman, Robert LJournal:
International Journal of Gynecologic Cancer
DOI:
10.1136/ijgc-2020-001863
Date:
October, 2020
File:
PDF, 1.22 MB
2020